ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $903,912 | +30.2% | 149,407 | +67.0% | 0.00% | – |
| Q2 2023 | $694,326 | -9.7% | 89,475 | -33.7% | 0.00% | – |
| Q1 2023 | $768,947 | -1.0% | 134,903 | +2.3% | 0.00% | – |
| Q4 2022 | $776,496 | +12.0% | 131,833 | -39.1% | 0.00% | – |
| Q3 2022 | $693,000 | -70.9% | 216,537 | -59.2% | 0.00% | – |
| Q2 2022 | $2,380,000 | +12.7% | 531,287 | +34.3% | 0.00% | – |
| Q1 2022 | $2,112,000 | +555.9% | 395,487 | +2471.9% | 0.00% | – |
| Q3 2021 | $322,000 | -5.8% | 15,377 | -20.4% | 0.00% | – |
| Q2 2021 | $342,000 | -75.0% | 19,315 | -52.2% | 0.00% | – |
| Q4 2020 | $1,369,000 | -18.6% | 40,435 | -39.8% | 0.00% | – |
| Q3 2020 | $1,681,000 | +630.9% | 67,207 | +883.9% | 0.00% | – |
| Q2 2020 | $230,000 | – | 6,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |